Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,980,173
+$4,462,277 QoQ
Shares Held
663,233
-12.1% QoQ
Ownership
0.253%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. OGN ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,980,173 | 663,233 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,517,896 | 754,240 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,522,819 | 630,798 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,243,398 | 584,588 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,796,607 | 702,129 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,476,527 | 703,595 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $11,001,156 | 737,343 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,729,815 | 874,533 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,101,109 | 922,759 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,988,365 | 956,828 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,418,457 | 930,545 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,915,529 | 225,549 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,201,929 | 153,865 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,457,979 | 189,540 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $5,151,910 | 184,458 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,136,226 | 304,967 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,416,196 | 634,554 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $23,860,296 | 683,089 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,168,638 | 629,512 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,281,599 | 588,033 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,724,834 | 321,376 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||